Glenmark to Conduct Phase 1 Trials of Its Molecule on Cancer Patients
Glenmark Pharma said it had received approval from the Drug Controller General of India (DCGI) to conduct phase 1 clinical trials of its molecule, GRC...
Download Unicorn Signals App
Powered By EquityPandit
